However, Cy treatment significantly restored the SIRT3/ROS/NF-κB pathway, and inhibition of SIRT3 led to the ablation of Cy generated protective efficacy in CUMS mice, suggesting the crucial role of SIRT3 signaling in the treatment of depression. Here, NFKB1 is linked to depressive symptom measurement.